---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285414305.md"
description: "Exelixis shares are trading higher after Wells Fargo raised its price target on the stock from $35 to $40."
datetime: "2026-05-06T16:57:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285414305.md)
  - [en](https://longbridge.com/en/news/285414305.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285414305.md)
---

# 

Exelixis shares are trading higher after Wells Fargo raised its price target on the stock from $35 to $40.

### Related Stocks

- [EXEL.US](https://longbridge.com/en/quote/EXEL.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)

## Related News & Research

- [Ameritas Advisory Services LLC Purchases Shares of 34,270 Exelixis, Inc. $EXEL](https://longbridge.com/en/news/286523415.md)
- [Relay's treatment shown to shrink vascular malformations in mid-stage trial](https://longbridge.com/en/news/286890329.md)
- [NeOnc Advances Glioma Programs and Strengthens Financial Position](https://longbridge.com/en/news/286826865.md)
- [Enanta Pharma's RSV Bet And Immunology Ambitions](https://longbridge.com/en/news/286895623.md)
- [AbbVie Inc. $ABBV Shares Purchased by RiverFront Investment Group LLC](https://longbridge.com/en/news/286750290.md)